You can buy or sell Precipio and other stocks, options, ETFs, and crypto commission-free!
Precipio, Inc. Common Stock, also called Precipio, is a cancer diagnostics company, which engages in the development and provision of a platform designed to eradicate the problem of misdiagnosis. Read More Its products include MX-ICP and ICEme kits. The company was founded in March 1997 and is headquartered in New Haven, CT.
New Haven, Connecticut
52 Week High
52 Week Low
Associated PressMar 11
Precipio CEO Issues Shareholder Update Letter
This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation. This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation. NEW HAVEN, Conn., March 11, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), issues the following letter from CEO Ilan Danieli. Dear Shareholders, Following our recent quarterly confere...
Stock Price, News, & Analysis for Precipio
News stories about PRPO stock have been trending somewhat positive on Saturday, InfoTrie reports. The research firm identifies positive and negative press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Precipio earned a daily sentiment score of 0.6 on InfoTrie's scale. They also gave media headlines about the biotechnology company a news buzz of 10.0 ...
Associated PressMar 5
Continued ICP Orders From Japanese Customers
NEW HAVEN, Conn., March 05, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced today that it continues to receive both new and repeat business from customers in Japan for its ICP liquid biopsy enrichment technology. In Particular, Precipio’s EGFR Exon 20 assay is proving to be of substantial clinical interest in the Japanese hospital market. Recently, Kyorin University Hospital in Tokyo, placed its third order for Precipio’s ICP assay. The RUO reagents kit wil...
-$1.01 per share
Expected Mar 28, After Hours